Xin Nakanishi - Net Worth and Insider Trading
Xin Nakanishi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Xin Nakanishi owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Xin Nakanishi’s form 4 insider trades.
Insider Ownership Summary of Xin Nakanishi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ONCT | Oncternal Therapeutics Inc | 2019-06-07 | director |
Xin Nakanishi Trading Performance
Xin Nakanishi Ownership Network
Xin Nakanishi Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Xin Nakanishi is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Xin Nakanishi made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Xin Nakanishi Mailing Address
Above is the net worth, insider trading, and ownership report for Xin Nakanishi. You might contact Xin Nakanishi via mailing address: C/o Oncternal Therapeutics, Inc., 3525 Del Mar Heights Road #821, San Diego Ca 92121.